Finance

Lists
Why is 4594 up 4,65%?
Dive Deeper
4594:TYO
BrightPath Biotherapeutics Co Ltd
45,00 JP¥
+4,65%
(+2,00) 1D
9 հոկ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4594...
Open
43 JP¥
High
45 JP¥
Low
42 JP¥
Mkt. cap
6,25 մլրդ
Avg. vol.
1,62 մլն
Volume
1,34 մլն
52-wk high
96 JP¥
52-wk low
42 JP¥
EPS
-13 JP¥
Shares outstanding
41,98 մլն
No. of employees
23
Open
43 JP¥
High
45 JP¥
Low
42 JP¥
Mkt. cap
6,25 մլրդ
Avg. vol.
1,62 մլն
Volume
1,34 մլն
52-wk high
96 JP¥
52-wk low
42 JP¥
EPS
-13 JP¥
Shares outstanding
41,98 մլն
No. of employees
23
News stories
From web sources and news partners
About BrightPath Biotherapeutics Co Ltd
CEO-
Employees23
Founded08 մյս, 2003 թ.
Headquarters-
Sector-
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
Revenue
16,50 հզր
16,50 հզր
-
51,00 հզր
Cost of goods sold
4,00 հզր
4,00 հզր
-
21,00 հզր
Cost of revenue
4,00 հզր
4,00 հզր
-
21,00 հզր
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
232,30 մլն
232,30 մլն
492,02 մլն
338,44 մլն
Operating expense
232,30 մլն
232,30 մլն
492,02 մլն
338,44 մլն
Total operating expenses
232,30 մլն
232,30 մլն
492,02 մլն
338,46 մլն
Operating income
-232,29 մլն
-232,29 մլն
-492,02 մլն
-338,41 մլն
Other non operating income
2,39 մլն
2,39 մլն
4,27 մլն
-18,95 մլն
EBT including unusual items
-230,76 մլն
-230,76 մլն
-491,75 մլն
-349,25 մլն
EBT excluding unusual items
-230,47 մլն
-230,47 մլն
-491,75 մլն
-358,87 մլն
Income tax expense
605,00 հզր
605,00 հզր
605,00 հզր
605,00 հզր
Effective tax rate
-0,26%
-0,26%
-0,12%
-0,17%
Other operating expenses
-
-
-
-
Net income
-231,37 մլն
-231,37 մլն
-492,36 մլն
-349,86 մլն
Net profit margin
-1 402 233,33%
-1 402 233,33%
-
-685 998,04%
Earnings per share
-
-
-
-
Interest and investment income
6,00 հզր
6,00 հզր
-
4,00 հզր
Interest expense
-
-
-
-
Net interest expenses
6,00 հզր
6,00 հզր
-
4,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps